2012
DOI: 10.1016/j.mvr.2012.08.004
|View full text |Cite
|
Sign up to set email alerts
|

Age-related decrease in cerebrovascular-derived neuroprotective proteins: Effect of acetaminophen

Abstract: As the population ages, the need for effective methods to maintain brain function in older adults is increasingly pressing. Vascular disease and neurodegenerative disorders commonly co-occur in older persons. Cerebrovascular products contribute to the neuronal milieu and have important consequences for neuronal viability. In this regard vascular derived neuroprotective proteins, such as vascular endothelial growth factor (VEGF), pigment epithelium-derived factor (PEDF), and pituitary adenylate cyclase activati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
19
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(20 citation statements)
references
References 96 publications
(124 reference statements)
1
19
0
Order By: Relevance
“…The vascular relaxation to PACAP1-38 is reduced with aging, which is similar to our previous observations in old rats [11]. An age-related decrease in PACAP mRNA and protein levels [16,31] can alter PACAP-induced relaxation. Accordingly, in the old rat brain, Lee et al [26] reported increased PAC1R and unchanged VPAC2R levels with aging, which implies the adaptation of the PACAP system for either compensation (in the form of receptor overexpression) or switch to “alternative” PACAP-mediated responses (most likely VIP).…”
Section: Discussionsupporting
confidence: 88%
See 3 more Smart Citations
“…The vascular relaxation to PACAP1-38 is reduced with aging, which is similar to our previous observations in old rats [11]. An age-related decrease in PACAP mRNA and protein levels [16,31] can alter PACAP-induced relaxation. Accordingly, in the old rat brain, Lee et al [26] reported increased PAC1R and unchanged VPAC2R levels with aging, which implies the adaptation of the PACAP system for either compensation (in the form of receptor overexpression) or switch to “alternative” PACAP-mediated responses (most likely VIP).…”
Section: Discussionsupporting
confidence: 88%
“…Therefore, VIP may stimulate the same second level signaling related to PACAP, thus it can counterbalance the increased contractility. These findings could have physiological importance as VIP can provide a counterbalancing mechanism preserving vasodilation in PACAP-deficiency or PACAP-insufficiency, which can be present in pathological conditions [14] and aging [16]. …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…We also showed that microvascular cerebral endothelial cells expressed PACAP. In accordance, isolated brain microvessels have been shown to release PACAP, e.Proofing http://eproofing.springer.com/printpage.php?token=GAdkHsZ-KwYI... which is decreasing with age (Tripathy et al 2012 ).…”
Section: Discussionmentioning
confidence: 89%